Detalhe da pesquisa
1.
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
Cancer
; 130(7): 1101-1111, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100619
2.
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Pediatr Blood Cancer
; 71(1): e30735, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37859597
3.
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Pediatr Blood Cancer
; : e31089, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822537
4.
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
Pediatr Blood Cancer
; 70(4): e30227, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720647
5.
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Cancer
; 128(15): 2967-2977, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665495
6.
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Pediatr Blood Cancer
; 68(3): e28794, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205902
7.
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(1): 121-133, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812554
8.
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
Cancer
; 126(2): 416-424, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584705
9.
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
Pediatr Blood Cancer
; 67(8): e28218, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472953
10.
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Pediatr Blood Cancer
; 67(10): e28390, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710697
11.
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 67(8): e28359, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472746
12.
In Memoriam: Sharon B. Murphy, MD (1943-2023).
Pediatr Blood Cancer
; 71(2): e30797, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037198
13.
The challenge of defining "ultra-high-risk" neuroblastoma.
Pediatr Blood Cancer
; 66(4): e27556, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479064
14.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
Pediatr Blood Cancer
; 66(7): e27736, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968542
15.
Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy.
Biol Blood Marrow Transplant
; 24(3): 452-459, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191664
16.
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
Pediatr Blood Cancer
; 65(12): e27417, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198643
17.
Rethinking high-risk neuroblastoma treatment.
Pediatr Blood Cancer
; 69(8): e29730, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35441788
18.
Genetic discoveries and treatment advances in neuroblastoma.
Curr Opin Pediatr
; 28(1): 19-25, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26576010
19.
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
Pediatr Blood Cancer
; 63(6): 1019-23, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864375
20.
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Pediatr Blood Cancer
; 63(8): 1349-56, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092812